Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001083962.2(TCF4):c.514_517delAAAG(p.Lys172PhefsTer61) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
TCF4 (HGNC:11634): (transcription factor 4) This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor. The encoded protein recognizes an Ephrussi-box ('E-box') binding site ('CANNTG') - a motif first identified in immunoglobulin enhancers. This gene is broadly expressed, and may play an important role in nervous system development. Defects in this gene are a cause of Pitt-Hopkins syndrome. In addition, an intronic CTG repeat normally numbering 10-37 repeat units can expand to >50 repeat units and cause Fuchs endothelial corneal dystrophy. Multiple alternatively spliced transcript variants that encode different proteins have been described. [provided by RefSeq, Jul 2016]
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-55350390-ACTTT-A is Pathogenic according to our data. Variant chr18-55350390-ACTTT-A is described in ClinVar as [Pathogenic]. Clinvar id is 93545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-55350390-ACTTT-A is described in Lovd as [Pathogenic]. Variant chr18-55350390-ACTTT-A is described in Lovd as [Likely_pathogenic].
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jun 30, 2016
Clinical Genetics and Genomics, Karolinska University Hospital
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jun 28, 2016
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Aug 28, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22045651, 25167861, 31105003, 32959227, 26147798, 28569743, 25780760, 22722829, 31785789, 22460224) -
Pitt-Hopkins syndrome Pathogenic:3
Feb 11, 2019
Centogene AG - the Rare Disease Company
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This sequence change creates a premature translational stop signal (p.Lys172Phefs*61) in the TCF4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCF4 are known to be pathogenic (PMID: 18728071, 22045651). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Pitt-Hopkins syndrome (PMID: 22045651). For these reasons, this variant has been classified as Pathogenic. -
May 15, 2019
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Neurodevelopmental disorder Pathogenic:1
Feb 21, 2020
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Intellectual disability Pathogenic:1
Jul 25, 2014
Diagnostic Laboratory, Strasbourg University Hospital
Significance: Pathogenic
Review Status: criteria provided, single submitter